1. Home
  2. VHC vs CYPH Comparison

VHC vs CYPH Comparison

Compare VHC & CYPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VirnetX Holding Corp

VHC

VirnetX Holding Corp

HOLD

Current Price

$13.39

Market Cap

79.2M

Sector

Miscellaneous

ML Signal

HOLD

CYPH

Cypherpunk Technologies Inc.

N/A

Current Price

$1.10

Market Cap

73.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VHC
CYPH
Founded
2005
2011
Country
United States
United States
Employees
N/A
6
Industry
Multi-Sector Companies
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
79.2M
73.4M
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
VHC
CYPH
Price
$13.39
$1.10
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
9.0K
3.1M
Earning Date
05-13-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
0.99
N/A
EPS
N/A
N/A
Revenue
$162,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
3140.00
N/A
52 Week Low
$6.60
$0.50
52 Week High
$29.00
$3.70

Technical Indicators

Market Signals
Indicator
VHC
CYPH
Relative Strength Index (RSI) 50.00 59.69
Support Level $12.95 $0.86
Resistance Level $18.26 $1.14
Average True Range (ATR) 0.99 0.12
MACD -0.02 0.02
Stochastic Oscillator 51.66 58.80

Price Performance

Historical Comparison
VHC
CYPH

About VHC VirnetX Holding Corp

VirnetX Holding Corp is engaged in the business of commercializing a portfolio of patents. It is an Internet security software and technology company with patented technology for secure communications. The company's software and technology solutions, including its Secure Domain Name Registry and Technology, VirnetX One, War Room, VirnetX Matrix, and GABRIEL Connection Technology, are designed to be device and location-independent, and enable a secure real-time communication environment for all types of enterprise applications, services and critical infrastructures.

About CYPH Cypherpunk Technologies Inc.

Cypherpunk Technologies Inc is a privacy technology company focused on implementing a digital asset treasury business anchored by Zcash, which is a cryptographic digital asset that operates on a decentralized, open-source blockchain network known as the Zcash Network. Through its subsidiary, the company is also engaged in developing novel therapies for patients with cancer. The group holds Zcash as part of its digital treasury business and has the following drug candidates under development in its biopharma business: Sirexatamab (DKN-01), a monoclonal antibody that inhibits Dickkopf-related protein 1, or DKK1; and a preclinical antibody program, FL-501, that is designed to treat cachexia-related indications.

Share on Social Networks: